HighTower Advisors’s Champions Oncology CSBR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Hold |
35,158
| – | – | ﹤0.01% | 3041 |
|
|
2025
Q1 | $305K | Sell |
35,158
-4,150
| -11% | -$36K | ﹤0.01% | 2846 |
|
|
2024
Q4 | $337K | Hold |
39,308
| – | – | ﹤0.01% | 2781 |
|
|
2024
Q3 | $191K | Buy |
39,308
+5,000
| +15% | +$24.3K | ﹤0.01% | 3137 |
|
|
2024
Q2 | $178K | Hold |
34,308
| – | – | ﹤0.01% | 3040 |
|
|
2024
Q1 | $168K | Buy |
34,308
+3,070
| +10% | +$15K | ﹤0.01% | 3011 |
|
|
2023
Q4 | $169K | Hold |
31,238
| – | – | ﹤0.01% | 3037 |
|
|
2023
Q3 | $194K | Hold |
31,238
| – | – | ﹤0.01% | 2910 |
|
|
2023
Q2 | $196K | Hold |
31,238
| – | – | ﹤0.01% | 2865 |
|
|
2023
Q1 | $126K | Hold |
31,238
| – | – | ﹤0.01% | 2863 |
|
|
2022
Q4 | $141K | Buy |
31,238
+4,771
| +18% | +$21.5K | ﹤0.01% | 2839 |
|
|
2022
Q3 | $199K | Hold |
26,467
| – | – | ﹤0.01% | 2599 |
|
|
2022
Q2 | $214K | Hold |
26,467
| – | – | ﹤0.01% | 2569 |
|
|
2022
Q1 | $215K | Hold |
26,467
| – | – | ﹤0.01% | 2753 |
|
|
2021
Q4 | $212K | Hold |
26,467
| – | – | ﹤0.01% | 2702 |
|
|
2021
Q3 | $270K | Buy |
26,467
+7,040
| +36% | +$71.8K | ﹤0.01% | 2476 |
|
|
2021
Q2 | $200K | Hold |
19,427
| – | – | ﹤0.01% | 2655 |
|
|
2021
Q1 | $220K | Buy |
19,427
+2,827
| +17% | +$32K | ﹤0.01% | 2520 |
|
|
2020
Q4 | $179K | Hold |
16,600
| – | – | ﹤0.01% | 2196 |
|
|
2020
Q3 | $154K | Hold |
16,600
| – | – | ﹤0.01% | 2128 |
|
|
2020
Q2 | $159K | Hold |
16,600
| – | – | ﹤0.01% | 2016 |
|
|
2020
Q1 | $123K | Hold |
16,600
| – | – | ﹤0.01% | 1890 |
|
|
2019
Q4 | $138K | Buy |
+16,600
| New | +$138K | ﹤0.01% | 2028 |
|